[taylor&francis]
Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease
文献作者：Heike Pfeifer; Wolfgang Bethge; Stefan Schonland; Lisa Heberling; Leo Ruhnke; Michael Stadler; Dietrich Beelen; Vladan Vucinic; Thomas Burmeister; Matthias Stelljes; Christoph Faul; Alexander Kiani; Knut Wendelin; Rainer Schwerdtfeger; Elisabeth Lange; Boris Kubuschok; Heinz-August Horst; Martin Gramatzki; Hubert Serve; Dieter Hoelzer; Nicola Gokbuget; Oliver G. Ottmann; Fabian Lang;
10